With a campus in Welwyn Garden City, Hertfordshire, our pharmaceutical business plays a significant role in advancing healthcare in the UK. Our UK site is a key part of Roche’s global research and development (R&D) programme, the largest of any healthcare company in the world. A key reason for this is the wealth of scientific talent in the UK, and the key partnerships that we have with universities, the NHS, regulators and Government. In 2020, we invested over £400 million into UK research, which equates to 8.5% of the total UK government spending on healthcare research.
Our passion for improving the lives of people across the UK is reflected in the next stage of the journey in developing new treatments - taking them from the lab to the real world. Since 2018, every single new Roche medicine that we’ve brought to market in the UK is available on the NHS.
Today and more than ever before, we have a wealth of opportunity ahead of us to make a significant difference to thousands of people in the UK. Our work never finishes; our aim is to always think bigger, be better and solve faster. I am so proud to lead an organisation which truly delivers for people in the UK.
Roche UK Impact study
March 2022 / M-GB-00006690
M-GB-00011728 Date of Preparation March 2023